Correlation Between Opthea and Pmv Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Opthea and Pmv Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Opthea and Pmv Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Opthea and Pmv Pharmaceuticals, you can compare the effects of market volatilities on Opthea and Pmv Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Opthea with a short position of Pmv Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Opthea and Pmv Pharmaceuticals.
Diversification Opportunities for Opthea and Pmv Pharmaceuticals
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Opthea and Pmv is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Opthea and Pmv Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pmv Pharmaceuticals and Opthea is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Opthea are associated (or correlated) with Pmv Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pmv Pharmaceuticals has no effect on the direction of Opthea i.e., Opthea and Pmv Pharmaceuticals go up and down completely randomly.
Pair Corralation between Opthea and Pmv Pharmaceuticals
Considering the 90-day investment horizon Opthea is expected to under-perform the Pmv Pharmaceuticals. In addition to that, Opthea is 1.67 times more volatile than Pmv Pharmaceuticals. It trades about -0.12 of its total potential returns per unit of risk. Pmv Pharmaceuticals is currently generating about 0.07 per unit of volatility. If you would invest 164.00 in Pmv Pharmaceuticals on September 4, 2024 and sell it today you would earn a total of 5.00 from holding Pmv Pharmaceuticals or generate 3.05% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Opthea vs. Pmv Pharmaceuticals
Performance |
| Timeline |
| Opthea |
| Pmv Pharmaceuticals |
Opthea and Pmv Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Opthea and Pmv Pharmaceuticals
The main advantage of trading using opposite Opthea and Pmv Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Opthea position performs unexpectedly, Pmv Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will offset losses from the drop in Pmv Pharmaceuticals' long position.| Opthea vs. Molecular Partners AG | Opthea vs. MediciNova | Opthea vs. Anebulo Pharmaceuticals | Opthea vs. Champions Oncology |
| Pmv Pharmaceuticals vs. Eliem Therapeutics | Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |